Abstract
The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed immunohistochemistry to detect cathepsin D in 115 tissue specimens 35 cases showed a positive reaction. In the univariate analysis cathepsin D expression showed significant prognostic value for overall survival (P-value = 0.007). In the multivariate analysis with established prognostic parameters (stage, grade) we found an independent prognostic value for cathepsin D (P-value = 0.002, relative risk = 3.8, 95% confidence interval 1.4 - 10.0). Immunohistochemical detection of cathepsin D could aid in predicting prognosis and planning therapy for patients with endometrial adenocarcinoma.
Full text
PDF



Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baltzer J., Lohe K. J., Kuerzl R., Scheer K. P., Zander J. Prognostic criteria in patients with endometrial cancer. Arch Gynecol. 1983;234(2):121–129. doi: 10.1007/BF00207684. [DOI] [PubMed] [Google Scholar]
- Cardiff R. D. Cathepsin D and breast cancer: useful? Hum Pathol. 1994 Sep;25(9):847–848. doi: 10.1016/0046-8177(94)90001-9. [DOI] [PubMed] [Google Scholar]
- Castiglioni T., Merino M. J., Elsner B., Lah T. T., Sloane B. F., Emmert-Buck M. R. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol. 1994 Sep;25(9):857–862. doi: 10.1016/0046-8177(94)90003-5. [DOI] [PubMed] [Google Scholar]
- Christopherson W. M., Connelly P. J., Alberhasky R. C. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease. Cancer. 1983 May 1;51(9):1705–1709. doi: 10.1002/1097-0142(19830501)51:9<1705::aid-cncr2820510924>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
- Creasman W. T. Adenocarcinoma of the uterine corpus. Curr Opin Obstet Gynecol. 1993 Feb;5(1):80–83. [PubMed] [Google Scholar]
- Creasman W. T. Prognostic significance of hormone receptors in endometrial cancer. Cancer. 1993 Feb 15;71(4 Suppl):1467–1470. doi: 10.1002/cncr.2820710411. [DOI] [PubMed] [Google Scholar]
- Greco N. J., Tenner T. E., Jr, Tandon N. N., Jamieson G. A. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change. Blood. 1990 May 15;75(10):1989–1990. [PubMed] [Google Scholar]
- Hendrickson M., Ross J., Eifel P., Martinez A., Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982 Mar;6(2):93–108. doi: 10.1097/00000478-198203000-00002. [DOI] [PubMed] [Google Scholar]
- Henry J. A., McCarthy A. L., Angus B., Westley B. R., May F. E., Nicholson S., Cairns J., Harris A. L., Horne C. H. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study. Cancer. 1990 Jan 15;65(2):265–271. doi: 10.1002/1097-0142(19900115)65:2<265::aid-cncr2820650214>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- Maudelonde T., Martinez P., Brouillet J. P., Laffargue F., Pages A., Rochefort H. Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. J Clin Endocrinol Metab. 1990 Jan;70(1):115–121. doi: 10.1210/jcem-70-1-115. [DOI] [PubMed] [Google Scholar]
- Nazeer T., Church K., Amato C., Ambros R. A., Rosano T. G., Malfetano J. H., Ross J. S. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness. Mod Pathol. 1994 May;7(4):469–474. [PubMed] [Google Scholar]
- Nazeer T., Malfetano J. H., Rosano T. G., Ross J. S. Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma. Am J Clin Pathol. 1992 Jun;97(6):764–769. doi: 10.1093/ajcp/97.6.764. [DOI] [PubMed] [Google Scholar]
- Ng A. B., Reagan J. W. Incidence and prognosis of endometrial carcinoma by histologic grade and extent. Obstet Gynecol. 1970 Mar;35(3):437–443. [PubMed] [Google Scholar]
- Rochefort H. Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol. 1992;31(2):125–130. doi: 10.3109/02841869209088891. [DOI] [PubMed] [Google Scholar]
- Rochefort H., Capony F., Garcia M., Cavaillès V., Freiss G., Chambon M., Morisset M., Vignon F. Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J Cell Biochem. 1987 Sep;35(1):17–29. doi: 10.1002/jcb.240350103. [DOI] [PubMed] [Google Scholar]
- Rochefort H., Cavailles V., Augereau P., Capony F., Maudelonde T., Touitou I., Garcia M. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem. 1989;34(1-6):177–182. doi: 10.1016/0022-4731(89)90080-0. [DOI] [PubMed] [Google Scholar]
- Roger P., Montcourrier P., Maudelonde T., Brouillet J. P., Pages A., Laffargue F., Rochefort H. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol. 1994 Sep;25(9):863–871. doi: 10.1016/0046-8177(94)90004-3. [DOI] [PubMed] [Google Scholar]
- Spyratos F., Maudelonde T., Brouillet J. P., Brunet M., Defrenne A., Andrieu C., Hacene K., Desplaces A., Rouëssé J., Rochefort H. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet. 1989 Nov 11;2(8672):1115–1118. doi: 10.1016/s0140-6736(89)91487-6. [DOI] [PubMed] [Google Scholar]
- Tandon A. K., Clark G. M., Chamness G. C., Chirgwin J. M., McGuire W. L. Cathepsin D and prognosis in breast cancer. N Engl J Med. 1990 Feb 1;322(5):297–302. doi: 10.1056/NEJM199002013220504. [DOI] [PubMed] [Google Scholar]
- Thorpe S. M., Rochefort H., Garcia M., Freiss G., Christensen I. J., Khalaf S., Paolucci F., Pau B., Rasmussen B. B., Rose C. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res. 1989 Nov 1;49(21):6008–6014. [PubMed] [Google Scholar]
- Touitou I., Cavaillès V., Garcia M., Defrenne A., Rochefort H. Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells. Mol Cell Endocrinol. 1989 Oct;66(2):231–238. doi: 10.1016/0303-7207(89)90035-x. [DOI] [PubMed] [Google Scholar]

